Anticoagulation control and prediction of adverse events in patients with atrial fibrillation: a systematic review.

Anticoagulation control and prediction of adverse events in patients with atrial fibrillation: a systematic review.

BACKGROUND: To date, there has been no systematic examination of the relationship between international normalized ratio (INR) control measurements and the prediction of adverse events in patients with atrial fibrillation on oral anticoagulation. METHODS AND RESULTS: We searched MEDLINE, EMBASE, an...

Detaylı Bibliyografya
Asıl Yazarlar:	Wan, Y, Heneghan, C, Perera, R, Roberts, N, Hollowell, J, Glasziou, P, Bankhead, C, Xu, Y
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	2008

Benzer Materyaller

Adverse events in clinically complex elderly patients with atrial fibrillation according to oral anticoagulation statusResearch in context
Yazar:: Tommaso Bucci, ve diğerleri
Baskı/Yayın Bilgisi: (2024-12-01)

Rhythm control agents and adverse events in patients with atrial fibrillation.
Yazar:: Taylor, C, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Individualised prediction of major bleeding in patients with atrial fibrillation treated with anticoagulation
Yazar:: Anne Pernille Toft-Petersen, ve diğerleri
Baskı/Yayın Bilgisi: (2024-01-01)

Individualised prediction of major bleeding in patients with atrial fibrillation treated with anticoagulation.
Yazar:: Anne Pernille Toft-Petersen, ve diğerleri
Baskı/Yayın Bilgisi: (2024-01-01)

Anticoagulant management in patients with atrial fibrillation.
Yazar:: Fitzmaurice, D, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Machine Learning Approaches to Predict Major Adverse Cardiovascular Events in Atrial Fibrillation
Yazar:: Pedro Moltó-Balado, ve diğerleri
Baskı/Yayın Bilgisi: (2024-01-01)

3021 Haemodialysis and atrial fibrillation anticoagulation decisions
Yazar:: Stephen Bacchi, ve diğerleri
Baskı/Yayın Bilgisi: (2024-08-01)

Effects of Anticoagulant Therapy and Frailty in the Elderly Patients with Atrial Fibrillation
Yazar:: Ding J, ve diğerleri
Baskı/Yayın Bilgisi: (2024-02-01)

Coffee consumption and adverse cardiovascular events in patients with atrial fibrillation
Yazar:: Vasco Iten, ve diğerleri
Baskı/Yayın Bilgisi: (2024-12-01)

Time trends in atrial fibrillation-associated stroke and premorbid anticoagulation
Yazar:: Yiin, G, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

The Anticoagulation in Patients with Atrial Fibrillation: Rivaroxaban and Warfarin
Yazar:: I. Yu. Koroleva, ve diğerleri
Baskı/Yayın Bilgisi: (2016-11-01)

Algorithm for the Choice of Anticoagulant for Patients with Atrial Fibrillation
Yazar:: Yu. P. Skirdenko, ve diğerleri
Baskı/Yayın Bilgisi: (2020-05-01)

Atrial Fibrillation Ablation without Interruption of Anticoagulation
Yazar:: Pasquale Santangeli, ve diğerleri
Baskı/Yayın Bilgisi: (2011-01-01)

Challenging anticoagulation decisions in atrial fibrillation: a narrative review
Yazar:: Michael Griffin, ve diğerleri
Baskı/Yayın Bilgisi: (2024-10-01)

Biomarkers for Predicting Left Atrial or Left Atrial Appendage Thrombus in Anticoagulated Patients with Nonvalvular Atrial Fibrillation
Yazar:: Xue Zhou, ve diğerleri
Baskı/Yayın Bilgisi: (2020-01-01)

A systematic review of economic aspects of service interventions to increase anticoagulation use in atrial fibrillation
Yazar:: Jones, NR, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

Underuse of anticoagulation for atrial fibrillation - are we failing our patients?
Yazar:: Jones, N, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Atrial fibrillation – NICE 2021 update and the focus on anticoagulation
Yazar:: Jones, N, ve diğerleri
Baskı/Yayın Bilgisi: (2022)

CURRENT POSSIBILITIES OF ANTICOAGULANT THERAPY IN PATIENTS WITH ATRIAL FIBRILLATION
Yazar:: M. Yu. Gilyarov, ve diğerleri
Baskı/Yayın Bilgisi: (2015-10-01)

Anticoagulation therapy in atrial fibrillation after intracranial hemorrhage
Yazar:: A. S. Gerasimenko, ve diğerleri
Baskı/Yayın Bilgisi: (2021-05-01)

Challenges of anticoagulant treatment in atrial fibrillation with liver disease
Yazar:: Alina Doina Nicoara, ve diğerleri
Baskı/Yayın Bilgisi: (2024-10-01)

Anticoagulant therapy in catheter ablation of atrial fibrillation and flutter
Yazar:: M. V. Serova, ve diğerleri
Baskı/Yayın Bilgisi: (2021-09-01)

Anticoagulation for Atrial Fibrillation in Acute Coronary Syndrome Survivors Reduces Major Cardiovascular Events and Mortality
Yazar:: Łukasz Pyka MD, PhD, ve diğerleri
Baskı/Yayın Bilgisi: (2023-12-01)

Self-monitoring of oral anticoagulation: a systematic review and meta-analysis.
Yazar:: Heneghan, C, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Sex-specific comparative outcomes between oral anticoagulants in patients with atrial fibrillation: a systematic review and meta-analysis
Yazar:: Gregory Y H Lip, ve diğerleri
Baskı/Yayın Bilgisi: (2024-08-01)

Left Atrial Appendage Closure in Atrial Fibrillation: A World without Anticoagulation?
Yazar:: Tahmeed Contractor, ve diğerleri
Baskı/Yayın Bilgisi: (2011-01-01)

Moderate/severe biatrial dilation predicts adverse events after ablation in atrial fibrillation with heart failure
Yazar:: Yan Yao, ve diğerleri
Baskı/Yayın Bilgisi: (2024-10-01)

Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF)
Yazar:: Raffaele De Caterina, ve diğerleri
Baskı/Yayın Bilgisi: (2019-03-01)

PREDICTORS OF THE RISK OF HEMORRHAGIC EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION RECEIVING LONGTERM THERAPY WITH DIRECT ORAL ANTICOAGULANTS
Yazar:: A. А. Sokolova, ve diğerleri
Baskı/Yayın Bilgisi: (2017-12-01)

Characterization of atrial fibrillation adverse events reported in ibrutinib randomized controlled registration trials
Yazar:: Jennifer R. Brown, ve diğerleri
Baskı/Yayın Bilgisi: (2017-10-01)

Challenges of anticoagulant therapy in patients with atrial fibrillation in clinical practice.
Yazar:: Hobbs, R
Baskı/Yayın Bilgisi: (2012)

ANTICOAGULATION IN PATIENTS WITH ATRIAL-FIBRILLATION - EXPERT SOFTWARE MAY BE THE ANSWER
Yazar:: Fitzmaurice, D, ve diğerleri
Baskı/Yayın Bilgisi: (1994)

Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Renal Dysfunction
Yazar:: Z. D. Kobalava, ve diğerleri
Baskı/Yayın Bilgisi: (2021-03-01)

THE RISK OF BLEEDINGS IN PATIENTS WITH ATRIAL FIBRILLATION DURING ANTICOAGULANT THERAPY
Yazar:: M. Yu. Gilyarov
Baskı/Yayın Bilgisi: (2015-12-01)

Type 2 Diabetes, Atrial Fibrillation, and Direct Oral Anticoagulation
Yazar:: Dana Prídavková, ve diğerleri
Baskı/Yayın Bilgisi: (2019-01-01)

Factors determining adherence to anticoagulant therapy in patients with atrial fibrillation
Yazar:: D. V. Pevzner, ve diğerleri
Baskı/Yayın Bilgisi: (2023-06-01)

Specifics of anticoagulation in combination with atrial fibrillation and chronic kidney disease
Yazar:: N. Sh. Zagidullin, ve diğerleri
Baskı/Yayın Bilgisi: (2021-10-01)

NOVEL ANTICOAGULANTS FOR THROMBOEMBOLIC COMPLICATIONS PREVENTION IN NONVALVULAR ATRIAL FIBRILLATION
Yazar:: D. A. Itkin, ve diğerleri
Baskı/Yayın Bilgisi: (2015-02-01)

Contribution of anticoagulant therapy adherence to the risk of complications of atrial fibrillation
Yazar:: Yu. P. Skirdenko, ve diğerleri
Baskı/Yayın Bilgisi: (2019-03-01)

New safety standards for anticoagulant therapy in the treatment of atrial fibrillation
Yazar:: E. I. Baranova
Baskı/Yayın Bilgisi: (2018-11-01)